Literature DB >> 24086850

Asymptomatic obese hypertensives and need of routine echocardiography for left ventricular mass assessment and treatment.

Bindu Garg1, Nirmal Yadav, Harsha Vardhan, A K De.   

Abstract

BACKGROUND: Echocardiographic determination of Left Ventricle Mass (LVM) - an important marker of cardiovascular disease, has been given a lot of importance in clinical diagnosis and in planning of treatment. Clinically asymptomatic compensated hypertensives show some pathological findings which are indicative of left ventricular dysfunction.
METHODS: The study population of 106 males, after a detailed clinical examination, were evaluated by echocardiography and were classified as per the body mass index classification of WHO Western Pacific Region in 2000 for Asian population. Fasting blood samples were taken to estimate blood sugar and lipid profile.
RESULTS: It was observed that subjects in normal range of body mass index <45 years (23.68%) and >45 years (16.1%), subjects of overweight <45 years (15.7%) and >45 years (10.29%) and obese I and II<45 years (60.52%) and >45 years (73.52%). The comparison between left ventricular mass which was indexed to height(2.7) in subjects who were <45 years and >45years was observed to be statistically significant (p<0.03). On comparing LVM/ht(2.7) of normal BMI group with that of those with higher BMIs, it was noted to be significantly different (p<0.009), which was suggestive of adverse effects of increasing BMI on LVM. It was also observed that persons with increased BMIs showed changes in left ventricular geometry - 30.13% had concentric hypertrophy, 17.80% had concentric remodeling, 8.21% had eccentric hypertrophy and that 38.35% had normal left ventricle geometry.
CONCLUSION: The present study therefore, indicated that it was better to do an echocardiographic screening of asymptomatic subjects who had even a marginal increase in blood pressure and BMI, to diagnose potential cardiac dysfunction.

Entities:  

Keywords:  Echocardiography; Hypertension; Left ventricular geometry; Left ventricular mass; Obesity

Year:  2013        PMID: 24086850      PMCID: PMC3782907          DOI: 10.7860/JCDR/2013/6227.3235

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  36 in total

1.  Prognostic impact of the indexation of left ventricular mass in patients undergoing dialysis.

Authors:  Carmine Zoccali; Francesco Antonio Benedetto; Francesca Mallamaci; Giovanni Tripepi; Giuseppe Giacone; Alessandro Cataliotti; Giuseppe Seminara; Benedetta Stancanelli; Lorenzo Salvatore Malatino
Journal:  J Am Soc Nephrol       Date:  2001-12       Impact factor: 10.121

Review 2.  Left ventricular hypertrophy in hypertension: its arrhythmogenic potential.

Authors:  Thomas Kahan; Lennart Bergfeldt
Journal:  Heart       Date:  2005-02       Impact factor: 5.994

3.  Impact of different grades of body mass index on left ventricular structure and function.

Authors:  Rajesh G Kathrotia; Swapnil J Paralikar; Pinkesh V Rao; Elvy R Oommen
Journal:  Indian J Physiol Pharmacol       Date:  2010 Apr-Jun

4.  Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings.

Authors:  R B Devereux; D R Alonso; E M Lutas; G J Gottlieb; E Campo; I Sachs; N Reichek
Journal:  Am J Cardiol       Date:  1986-02-15       Impact factor: 2.778

5.  Blood pressure and echocardiographic measures in children: the Bogalusa Heart Study.

Authors:  G L Burke; R A Arcilla; W S Culpepper; L S Webber; Y K Chiang; G S Berenson
Journal:  Circulation       Date:  1987-01       Impact factor: 29.690

Review 6.  Molecular determinants of myocardial hypertrophy and failure: alternative pathways for beneficial and maladaptive hypertrophy.

Authors:  Daniel J Lips; Leon J deWindt; Dave J W van Kraaij; Pieter A Doevendans
Journal:  Eur Heart J       Date:  2003-05       Impact factor: 29.983

7.  Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial.

Authors:  Richard B Devereux; Björn Dahlöf; Eva Gerdts; Kurt Boman; Markku S Nieminen; Vasilios Papademetriou; Jens Rokkedal; Katherine E Harris; Jonathan M Edelman; Kristian Wachtell
Journal:  Circulation       Date:  2004-08-23       Impact factor: 29.690

8.  Influence of left ventricular geometric patterns on prognosis in patients with or without coronary artery disease.

Authors:  J K Ghali; Y Liao; R S Cooper
Journal:  J Am Coll Cardiol       Date:  1998-06       Impact factor: 24.094

9.  Echocardiographic assessment of inappropriate left ventricular mass and left ventricular hypertrophy in patients with diastolic dysfunction.

Authors:  Hasan Shemirani; Rohola Hemmati; Alireza Khosravi; Mojgan Gharipour; Mahnaz Jozan
Journal:  J Res Med Sci       Date:  2012-02       Impact factor: 1.852

10.  Assessment of left ventricular geometrical patterns and function among hypertensive patients at a tertiary hospital, Northern Tanzania.

Authors:  Lairumbe Korduni Silangei; Venance Philis Maro; Helmut Diefenthal; Gibson Kapanda; Matthew Dewhurst; Hery Mwandolela; Ben Hamel
Journal:  BMC Cardiovasc Disord       Date:  2012-11-23       Impact factor: 2.298

View more
  1 in total

1.  Impact of prehypertension on left ventricular structure, function and geometry.

Authors:  Jugal Kishore Bajpai; Sahay A P; Agarwal A K; De A K; Bindu Garg; Ashish Goel
Journal:  J Clin Diagn Res       Date:  2014-04-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.